LPCN - Lipocine: TLANDO Might Become A Potential TRT Option In Patients With COVID-19 Infection
- Lipocine is about to report data from its clinical study on whether TLANDO can restore testosterone levels in hypogonadal men without the dose titration requirement on November 9, 2020.
- Low baseline testosterone levels result in a higher risk of serious complications or even death in patients with COVID-19 infection.
- Testosterone replacement treatment using TLANDO might save plenty of lives of elderly men who are infected with COVID-19 infection.
For further details see:
Lipocine: TLANDO Might Become A Potential TRT Option In Patients With COVID-19 Infection